Ameren Corp (AEE) director Rafael Flores amends filing on 626-share stock sale

Rhea-AI Filing Summary

Ameren Corp director Rafael Flores reported an amended insider transaction involving Ameren Corp (AEE) common stock. On 11/17/2025, he sold 626 shares of common stock at a weighted average price of $105.32 per share, as part of multiple trades within a price range of $105.21 to $105.38. Following this sale, he beneficially owned 13,772 shares directly, which include 291 shares acquired during the first through third quarters of 2025 through reinvested dividends. The current filing is an amendment to the Form 4 originally filed on November 18, 2025, and is being made to correct the reported number of shares sold, the sale price, and the post-transaction share balance.

Insider Trade Summary

Net Seller: 626 shares ($65,930)

Net Sell 1 txn

Insider Flores Rafael

Role Director

Sold 626 shs ($66K)

Type	Security	Shares	Price	Value
Sale	Common Stock, $.01 Par Value	626	$105.32	$66K

Holdings After Transaction: Common Stock, $.01 Par Value — 13,772 shares (Direct)

Footnotes (1)

1. This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.21 to $105.38. The reporting person undertakes to provide Ameren Corporation (Ameren), any security holder of Ameren, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Amount includes a total of 291 shares acquired during the first through third quarters of 2025 through reinvested dividends.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Flores Rafael

(Last) (First) (Middle)

1901 CHOUTEAU AVE, MC 1310

P.O. BOX 66149

(Street)

ST. LOUIS MO 63166-6149

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMEREN CORP [ AEE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
11/18/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 Par Value	11/17/2025		S		626	D	$105.32(1)	13,772(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.21 to $105.38. The reporting person undertakes to provide Ameren Corporation (Ameren), any security holder of Ameren, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

2. Amount includes a total of 291 shares acquired during the first through third quarters of 2025 through reinvested dividends.

Remarks:

This amended Form 4 is being filed to correct the number of shares sold, sale price, and amount of shares beneficially owned following the reported transaction as reflected in the original filing made on November 18, 2025.

	Jonathan T. Shade, Deputy Corp. Secy. of Ameren Corporation, attorney-in-fact for Rafael Flores	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Ameren Corp (AEE) report in this Form 4/A?

The filing reports that director Rafael Flores sold 626 shares of Ameren Corp common stock on 11/17/2025 at a weighted average price of $105.32 per share.

How many Ameren Corp (AEE) shares does Rafael Flores own after this transaction?

After the reported sale, Rafael Flores beneficially owned 13,772 shares of Ameren Corp common stock directly.

What price range applied to the Ameren (AEE) shares sold by Rafael Flores?

The 626 shares sold on 11/17/2025 were transacted at prices ranging from $105.21 to $105.38 per share, resulting in a weighted average price of $105.32.

Why is this Ameren Corp (AEE) Form 4/A labeled as an amendment?

The filing states that it is being amended to correct the number of shares sold, the sale price, and the amount of shares beneficially owned following the transaction as previously reported on November 18, 2025.

Does Rafael Flores’ Ameren (AEE) share balance include dividend reinvestments?

Yes. The filing explains that the 13,772 shares beneficially owned include 291 shares acquired during the first through third quarters of 2025 through reinvested dividends.

What is Rafael Flores’ role at Ameren Corp (AEE)?

The filing identifies Rafael Flores as a director of Ameren Corp.